Rhoen-Klinikum AG
Rhoen-Klinikum AG
Your view on RHKJF
Overview
What the company does, where it operates, and who runs it.
About Rhoen-Klinikum AG
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Stefan Stranz
- Headquarters
- Salzburger Leite 1, Bad Neustadt an der Saale, DE
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Stefan Stranz
- Headquarters
- Salzburger Leite 1, Bad Neustadt an der Saale, DE
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.
Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases.
It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Rhoen-Klinikum AG, and the rating behind it. RHKJF last traded at $15.30, 22.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Rhoen-Klinikum AG. Starting points for Rhoen-Klinikum AG: P/E 22.7, EPS $0.65, beta -0.05 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Rhoen-Klinikum AG. Rhoen-Klinikum AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Rhoen-Klinikum AG. Trailing twelve-month EPS for Rhoen-Klinikum AG stands at $0.65. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Rhoen-Klinikum AG. Rhoen-Klinikum AG has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Rhoen-Klinikum AG valued side by side against its closest peers. Rhoen-Klinikum AG is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Rhoen-Klinikum AG, and how their positions are changing. At a $1.02B market value, institutional positions materially move Rhoen-Klinikum AG's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Rhoen-Klinikum AG executives and directors. Shares of Rhoen-Klinikum AG have traded between $11.15 and $15.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Rhoen-Klinikum AG. Rhoen-Klinikum AG is a $1.02B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Rhoen-Klinikum AG. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Rhoen-Klinikum AG. Coverage tracks Rhoen-Klinikum AG within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.